MUC1 and pancreatic neoplasm: A similar idea about mAb action was proposed by Wu et al. in a pancreatic cancer model where anti-MUC1 induced the translocation of MUC1 into the cytoplasm and, in this way, inactivation of MUC1 oncogenic signaling was accomplished [40].